Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
- DOI
- 10.1161/circulationaha.126.080365
- Published
- 2026 Aug 29
- Container
- Circulation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1161/circulationaha.126.080365,
title = {Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.},
author = {Guedon AF and Cacoub P and Carrat F and Espitia O and Mirouse A and Ghrenassia E and Fain O and Mekinian A and Saadoun D},
year = {2026},
journal = {Circulation},
doi = {10.1161/circulationaha.126.080365},
url = {https://doi.org/10.1161/circulationaha.126.080365}
}RIS
TY - JOUR TI - Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis. AU - Guedon AF AU - Cacoub P AU - Carrat F AU - Espitia O AU - Mirouse A AU - Ghrenassia E AU - Fain O AU - Mekinian A AU - Saadoun D PY - 2026 JO - Circulation DO - 10.1161/circulationaha.126.080365 UR - https://doi.org/10.1161/circulationaha.126.080365 ER -
APA
AF, G., P, C., F, C., O, E., A, M., E, G., O, F., A, M., & D, S. (2026). Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.. Circulation. https://doi.org/10.1161/circulationaha.126.080365
Source records
- pubmed · retrieved 2026-09-26T10:26:05.846Z